Wada Yoko, Hasegawa Hisashi, Saeki Takako, Ito Satoshi, Kuroda Takeshi, Nakano Masaaki, Narita Ichiei
Division of Clinical Nephrology and Rheumatology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-ku, Niigata, 951-8510, Japan.
Division of Clinical Nephrology and Rheumatology, Niigata City General Hospital, Niigata, Japan.
Clin Exp Nephrol. 2018 Jun;22(3):597-602. doi: 10.1007/s10157-017-1491-9. Epub 2017 Oct 25.
Using a single-center cohort of Japanese patients with SLE, we attempted to clarify the long-term outcome and factors associated with damage accrual using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).
We examined a cohort of 557 patients who had been referred to Niigata University Hospital and diagnosed as having SLE between 1961 and 2013. The patients' data at the latest visit were collected from their clinical records, and causes of death were defined on the basis of those data. Survival from the time of diagnosis was calculated by the Kaplan-Meier method. The SDI was calculated and analyzed using Spearman's correlation coefficient and stepwise multiple regression analysis to reveal the factors associated with any organ damage.
Data from 458 of the patients were successfully obtained. The overall 5-year survival rate was 92.2%, and patients diagnosed after 2000 had a significantly high 5-year survival rate of 96.4%. Stepwise multiple regression analysis selected serum creatinine levels (B = 0.6051, p < 0.0001), age (standardized beta = 0.2762, p < 0.001), hypertension (standardized beta = 0.2267, p < 0.001), and antiphospholipid antibody syndrome (standardized beta = 0.1533, p = 0.005) as positive independent variables, whereas administration of bisphosphonate (standardized beta = - 0.1295, p = 0.016) was selected as a negative independent variable.
These results suggest that Japanese patients with SLE have a favorable long-term prognosis, and also indicate that disease control as well as management of chronic complications such as hypertension and osteoporosis has possible effects for prevention of organ damage.
我们利用一个日本系统性红斑狼疮(SLE)患者的单中心队列,试图使用系统性红斑狼疮国际协作临床/美国风湿病学会损伤指数(SDI)来阐明长期预后以及与损伤累积相关的因素。
我们研究了一组557例于1961年至2013年间转诊至新潟大学医院并被诊断为SLE的患者。从他们的临床记录中收集患者在最近一次就诊时的数据,并根据这些数据确定死亡原因。采用Kaplan-Meier法计算从诊断时起的生存率。计算SDI,并使用Spearman相关系数和逐步多元回归分析进行分析,以揭示与任何器官损伤相关的因素。
成功获取了458例患者的数据。总体5年生存率为92.2%,2000年后诊断的患者5年生存率显著较高,为96.4%。逐步多元回归分析选择血清肌酐水平(B = 0.6051,p < 0.0001)、年龄(标准化β = 0.2762,p < 0.001)、高血压(标准化β = 0.2267,p < 0.001)和抗磷脂抗体综合征(标准化β = 0.1533,p = 0.005)作为正性自变量,而双膦酸盐的使用(标准化β = -0.1295,p = 0.016)被选为负性自变量。
这些结果表明,日本SLE患者具有良好的长期预后,也表明疾病控制以及高血压和骨质疏松等慢性并发症的管理对预防器官损伤可能有作用。